![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/end-line-synlogic-biotech-lays-90-over-pku-drugs-phase-3-fail
https://www.globenewswire.com/news-release/2023/07/11/2702540/0/en/Synlogic-Partners-with-Science-37-on-Pivotal-Study-for-Investigational-Drug-for-Phenylketonuria-PKU.html
https://www.pharmaceutical-technology.com/news/synlogic-synb1934-orphan-drug/
https://www.fiercebiotech.com/biotech/sqz-ceo-exits-biotech-axes-60-staff-synlogic-succumbs-layoff-pressure
https://pharmaphorum.com/news/synlogic-preps-phenylketonuria-drug-for-phase-3-after-mid-stage-win/
https://investors.ginkgobioworks.com/news/news-details/2022/Synlogic-Announces-Synthetic-Biotic-for-Gout-Developed-in-Partnership-with-Ginkgo-Bioworks/default.aspx
https://www.prnewswire.com/news-releases/synlogic-announces-presentation-of-phenylketonuria-data-at-14th-international-congress-of-inborn-errors-of-metabolism-meeting-301420438.html
https://investor.synlogictx.com/news-releases/news-release-details/synlogic-and-ginkgo-bioworks-announce-investigational-synthetic
https://www.prnewswire.com/news-releases/synlogic-announces-nature-publication-demonstrating-novel-application-of-synthetic-biotic-platform-301398478.html